Vanguard Group Inc. Has $624.35 Million Stock Position in Bruker Co. (NASDAQ:BRKR)

Vanguard Group Inc. lessened its stake in Bruker Co. (NASDAQ:BRKR) by 0.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,650,853 shares of the medical research company’s stock after selling 47,322 shares during the quarter. Vanguard Group Inc. owned about 7.03% of Bruker worth $624,353,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. True Wealth Design LLC increased its holdings in shares of Bruker by 4,636.4% in the third quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock valued at $36,000 after purchasing an additional 510 shares in the last quarter. Eagle Bay Advisors LLC increased its stake in shares of Bruker by 2,324.1% in the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock valued at $41,000 after buying an additional 674 shares during the period. UMB Bank n.a. raised its position in shares of Bruker by 37.5% during the fourth quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock worth $53,000 after acquiring an additional 248 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Bruker by 47.5% during the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock valued at $75,000 after acquiring an additional 412 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its holdings in Bruker by 41.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company’s stock valued at $78,000 after acquiring an additional 390 shares during the last quarter. 79.52% of the stock is owned by institutional investors.

Analyst Ratings Changes

BRKR has been the subject of several recent research reports. Barclays dropped their price objective on Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, February 10th. The Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 target price for the company in a research report on Thursday, December 5th. Bank of America lifted their price objective on Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. Guggenheim restated a “buy” rating on shares of Bruker in a research report on Monday, February 24th. Finally, Stifel Nicolaus cut their price target on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research report on Friday, February 14th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $70.50.

Bruker Trading Down 3.2 %

NASDAQ BRKR opened at $42.08 on Monday. The stock has a market capitalization of $6.38 billion, a price-to-earnings ratio of 55.37, a PEG ratio of 2.16 and a beta of 1.18. Bruker Co. has a 52 week low of $41.80 and a 52 week high of $94.35. The stock’s 50 day moving average price is $50.54 and its two-hundred day moving average price is $56.91. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60.

Bruker (NASDAQ:BRKR) last announced its earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. As a group, analysts anticipate that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 17th were issued a dividend of $0.05 per share. The ex-dividend date was Monday, March 17th. This represents a $0.20 annualized dividend and a yield of 0.48%. Bruker’s payout ratio is presently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.